Cargando…

TROPONIN, ANTICOAGULATION, ATRIAL FIBRILLATION AND CORONAVIRUS DISEASE 19 IN PATIENTS WITH UNDERLYING CARDIAC DISEASE

Detalles Bibliográficos
Autores principales: Limani, Saurabhkumar M., Desai, Nayan Kirit, Yamini, Sundermurthy, Sturdevant, David, Feltman, Erin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Cardiology Foundation. Published by Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982901/
http://dx.doi.org/10.1016/S0735-1097(23)02604-9
_version_ 1784900427976802304
author Limani, Saurabhkumar M.
Desai, Nayan Kirit
Yamini, Sundermurthy
Sturdevant, David
Feltman, Erin
author_facet Limani, Saurabhkumar M.
Desai, Nayan Kirit
Yamini, Sundermurthy
Sturdevant, David
Feltman, Erin
author_sort Limani, Saurabhkumar M.
collection PubMed
description
format Online
Article
Text
id pubmed-9982901
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American College of Cardiology Foundation. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-99829012023-03-03 TROPONIN, ANTICOAGULATION, ATRIAL FIBRILLATION AND CORONAVIRUS DISEASE 19 IN PATIENTS WITH UNDERLYING CARDIAC DISEASE Limani, Saurabhkumar M. Desai, Nayan Kirit Yamini, Sundermurthy Sturdevant, David Feltman, Erin J Am Coll Cardiol Spotlight on Special Topics American College of Cardiology Foundation. Published by Elsevier Inc. 2023-03-07 2023-03-03 /pmc/articles/PMC9982901/ http://dx.doi.org/10.1016/S0735-1097(23)02604-9 Text en © 2023 American College of Cardiology Foundation Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Spotlight on Special Topics
Limani, Saurabhkumar M.
Desai, Nayan Kirit
Yamini, Sundermurthy
Sturdevant, David
Feltman, Erin
TROPONIN, ANTICOAGULATION, ATRIAL FIBRILLATION AND CORONAVIRUS DISEASE 19 IN PATIENTS WITH UNDERLYING CARDIAC DISEASE
title TROPONIN, ANTICOAGULATION, ATRIAL FIBRILLATION AND CORONAVIRUS DISEASE 19 IN PATIENTS WITH UNDERLYING CARDIAC DISEASE
title_full TROPONIN, ANTICOAGULATION, ATRIAL FIBRILLATION AND CORONAVIRUS DISEASE 19 IN PATIENTS WITH UNDERLYING CARDIAC DISEASE
title_fullStr TROPONIN, ANTICOAGULATION, ATRIAL FIBRILLATION AND CORONAVIRUS DISEASE 19 IN PATIENTS WITH UNDERLYING CARDIAC DISEASE
title_full_unstemmed TROPONIN, ANTICOAGULATION, ATRIAL FIBRILLATION AND CORONAVIRUS DISEASE 19 IN PATIENTS WITH UNDERLYING CARDIAC DISEASE
title_short TROPONIN, ANTICOAGULATION, ATRIAL FIBRILLATION AND CORONAVIRUS DISEASE 19 IN PATIENTS WITH UNDERLYING CARDIAC DISEASE
title_sort troponin, anticoagulation, atrial fibrillation and coronavirus disease 19 in patients with underlying cardiac disease
topic Spotlight on Special Topics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982901/
http://dx.doi.org/10.1016/S0735-1097(23)02604-9
work_keys_str_mv AT limanisaurabhkumarm troponinanticoagulationatrialfibrillationandcoronavirusdisease19inpatientswithunderlyingcardiacdisease
AT desainayankirit troponinanticoagulationatrialfibrillationandcoronavirusdisease19inpatientswithunderlyingcardiacdisease
AT yaminisundermurthy troponinanticoagulationatrialfibrillationandcoronavirusdisease19inpatientswithunderlyingcardiacdisease
AT sturdevantdavid troponinanticoagulationatrialfibrillationandcoronavirusdisease19inpatientswithunderlyingcardiacdisease
AT feltmanerin troponinanticoagulationatrialfibrillationandcoronavirusdisease19inpatientswithunderlyingcardiacdisease